A detailed history of Operose Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Operose Advisors LLC holds 4,313 shares of PFE stock, worth $111,404. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,313
Previous 1,343 221.15%
Holding current value
$111,404
Previous $37,000 235.14%
% of portfolio
0.04%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $82,269 - $93,228
2,970 Added 221.15%
4,313 $124,000
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $230,093 - $269,626
-9,109 Reduced 87.15%
1,343 $37,000
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $263,560 - $302,651
10,180 Added 3742.65%
10,452 $290,000
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $10,172 - $11,890
-317 Reduced 53.82%
272 $9,000
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $18,513 - $24,101
-470 Reduced 44.38%
589 $24,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $21,136 - $25,801
-483 Reduced 31.32%
1,059 $46,000
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $21,502 - $26,644
470 Added 43.84%
1,542 $80,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $44,295 - $65,660
1,072 New
1,072 $63,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.